ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

16,065Medicare Part D Prescriptions Filled, Including Refills

Rank: 188 out of 5176

$843K Total Retail Price of All Prescriptions

Rank: 402 out of 5176

318 Patients Receiving at Least One Drug in Part D
71%Patients 65 Years and Older
89% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in New York
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 318 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

17% of this provider’s 318 patients filled at least one prescription for a schedule three drug, compared to an average of 4%.

Risky Drugs to Seniors

1% of this provider’s 12,972 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

22% of this provider’s prescriptions were for brand-name drugs, compared to an average of 30%.

Prescription Price

$52 was the average price of a prescription from this provider, compared to $69 among peers.

Prescriptions per Patient

51 is the average number of prescriptions (including refills) per patient, compared to an average of 20.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in New York
OMEPRAZOLE 761 584 1 3
WARFARIN SODIUM 645 585 2 13
LEVOTHYROXINE SODIUM 543 440 3 4
SERTRALINE HCL 520 503 4 30
SIMVASTATIN 515 354 5 1
FUROSEMIDE 418 368 6 8
LISINOPRIL 378 288 7 5
AMLODIPINE BESYLATE 374 317 8 2
IPRATROPIUM-ALBUTEROL 351 346 9 138
DONEPEZIL HCL 345 345 10 28
METOPROLOL TARTRATE 276 251 11 6
HYDROCODONE-ACETAMINOPHEN 275 227 S3 12 27
BUSPIRONE HCL 251 236 13 183
NAMENDA 226 226 14 47
GABAPENTIN 201 172 15 21
POTASSIUM CHLORIDE 196 183 16 34
FLUTICASONE PROPIONATE 189 142 17 38
ALENDRONATE SODIUM 184 169 18 18
MIRTAZAPINE 178 172 19 45
TAMSULOSIN HCL 174 163 20 20
ENALAPRIL MALEATE 164 120 21 22
DIOVAN 157 113 22 19
DIVALPROEX SODIUM 148 134 23 104
LEVOFLOXACIN 147 130 24 109
FINASTERIDE 147 131 24 69
METFORMIN HCL 140 87 26 7
CARVEDILOL 139 134 27 24
LIDOCAINE-PRILOCAINE 119 119 28 340
PREDNISONE 119 115 28 52
METFORMIN HCL ER 118 73 30 57
KLOR-CON M20 117 115 31 129
CITALOPRAM HBR 117 114 31 31
NOVOLOG FLEXPEN 116 98 33 196
EXELON 113 113 34 162
ATENOLOL 113 73 34 12
RANITIDINE HCL 113 66 34 36
JANUVIA 110 75 37 25
PRAVASTATIN SODIUM 109 90 38 23
LEVETIRACETAM 108 61 39 92
ZOLPIDEM TARTRATE 107 65 40 17
ATORVASTATIN CALCIUM 105 67 41 9
LOVASTATIN 104 50 42 46
GLIPIZIDE ER 98 79 43 117
CLOPIDOGREL 97 81 44 26
RISPERIDONE 92 80 45 78
ADVAIR DISKUS 91 89 46 32
CRESTOR 89 76 47 15
ALBUTEROL SULFATE 88 76 48 99
TRIAMTERENE-HCTZ 86 79 49 86
TAMIFLU 86 80 49 231
METOPROLOL SUCCINATE 84 63 51 11
SPIRIVA 83 72 52 54
HYDRALAZINE HCL 81 66 53 73
LOSARTAN POTASSIUM 81 61 53 14
POLYETHYLENE GLYCOL 3350 79 42 55 74
MELOXICAM 78 75 56 53
SPS 76 76 57 415
TORSEMIDE 76 76 57 184
HYDROCHLOROTHIAZIDE 76 37 57 10
FENTANYL 74 74 S2 60 172
NEXIUM 74 31 60 16
AZITHROMYCIN 74 68 60 42
PLAVIX 70 53 63 29
ALLOPURINOL 69 66 64 41
GLIPIZIDE 68 55 65 63
BACLOFEN 67 38 66 173
GEMFIBROZIL 66 0 67 139
CARBIDOPA-LEVODOPA 65 53 68 98
DIGOXIN 62 62 69 56
SUCRALFATE 62 26 69 303
PROAIR HFA 61 23 71 60
LATANOPROST 60 60 72 185
SULFAMETHOXAZOLE-TRIMETHOPRIM 60 56 72 181
CLONIDINE HCL 59 40 74 79
BISOPROLOL FUMARATE 58 39 75 239
ESCITALOPRAM OXALATE 57 57 76 89
HYDROXYZINE PAMOATE 56 28 R 77 480
ROPINIROLE HCL 55 40 78 208
FAMOTIDINE 54 40 79 58
PAROXETINE HCL 53 52 80 93
BUDESONIDE 52 52 81 380
VENTOLIN HFA 51 13 82 64
QUETIAPINE FUMARATE 51 37 82 75
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 8, 2007.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.